Guardant Health, Inc. - Common Stock (NQ:GH)

Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Improving Cancer Screening Adherence at ACG 2025

October 26, 2025

Guardant Health and Collaborators to Present New Data Across the Cancer Care Continuum at ESMO 2025

Is Guardant Health Inc Gaining or Losing Market Support?

October 21, 2025

Via Benzinga

October 15, 2025

Guardant Health to Report Third Quarter 2025 Financial Results on October 29, 2025

October 09, 2025

A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared.

1 Volatile Stock to Research Further and 2 Facing Headwinds

October 07, 2025

Decoding Life's Blueprint: New Tech Maps RNA-Protein Interactions, Unlocking Disease Cures

Topics Initial Public Offering

What Does the Market Think About Guardant Health Inc?

October 03, 2025

Via Benzinga

October 02, 2025

A monumental leap in biomedical research has been announced with the development of a breakthrough technology capable of mapping the entire intricate network of RNA-protein interactions within human...

Via MarketMinute

Topics Artificial Intelligence Derivatives

Stocks making big moves yesterday: Beyond Meat, The Trade Desk, Guardant Health, PayPal, and Tilray

September 30, 2025

Check out the companies making headlines yesterday:

Shares of diagnostics company Guardant Health (NASDAQ:GH) jumped 1.6% in the morning session after the U.S. Food and Drug Administration (FDA) approved its Guardant360® CDx blood test as a companion...

Topics Cannabis Government

Why Guardant Health (GH) Stock Is Trading Up Today

September 29, 2025

FDA Approves Guardant360® CDx as Companion Diagnostic for Eli Lilly and Company’s Inluriyo™ (imlunestrant) for Treatment of ESR1-mutated Advanced Breast Cancer

September 29, 2025

Shares of diagnostics company Guardant Health (NASDAQ:GH) jumped 5.2% in the morning session after the company announced a collaboration with Quest Diagnostics and provided an upbeat financial outlook...

Guardant Health (GH) Stock Trades Up, Here Is Why

September 25, 2025

Guardant Health and Quest Diagnostics Announce Strategic Collaboration to Broaden Access to Guardant’s Shield™ Blood-based Screening Test in the United States

Topics Artificial Intelligence

September 24, 2025

Guardant Health’s 28.8% return over the past six months has outpaced the S&P 500 by 13.3%, and its stock price has climbed to $60.20 per share. This was partly due to its solid quarterly results, and...

3 Reasons to Avoid GH and 1 Stock to Buy Instead

September 24, 2025

Shares of diagnostics company Guardant Health (NASDAQ:GH) jumped 1.2% in the afternoon session after multiple financial analysts issued positive ratings on the stock. Canaccord Genuity reaffirmed its...

Topics Bankruptcy Stocks

Guardant Health (GH) Stock Is Up, What You Need To Know

September 23, 2025

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside...

Topics Artificial Intelligence Economy

3 Small-Cap Stocks We Approach with Caution

September 22, 2025

Testing & Diagnostics Services Q2 Earnings: Guardant Health (NASDAQ:GH) is the Best in the Biz

September 18, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how testing & diagnostics services stocks fared in Q2, starting...

Looking back on testing & diagnostics services stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Guardant Health (NASDAQ:GH) and its peers.

Q2 Earnings Recap: Guardant Health (NASDAQ:GH) Tops Testing & Diagnostics Services Stocks

September 17, 2025

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other...

3 Unpopular Stocks with Warning Signs

September 16, 2025

Alex M. Azar II Joins Guardant Health Board of Directors

September 15, 2025

Guardant Health Expands Access to Shield CRC Blood Test to Senior Living Communities with LabFlorida Partnership

September 11, 2025

Select Medical, Guardant Health, Artivion, PacBio, and Intuitive Surgical Shares Are Falling, What You Need To Know

September 10, 2025

A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading.

Guardant Health Announces Partnership with PathGroup Bringing Shield Blood Test to 250+ Hospitals and Health Systems in 25 States

Topics Economy Stocks

September 08, 2025

Shares of diagnostics company Guardant Health (NASDAQ:GH) fell 7.1% in the morning session after the company announced updated clinical results for its Shield blood-based colorectal cancer screening...

Why Guardant Health (GH) Shares Are Plunging Today

September 04, 2025

The company is working on a second version of its colon cancer screening test, Shield.

Topics Economy

Why IBD 50's Guardant Health Just Tumbled, Breaking A 67% Monthlong Run

September 04, 2025

Via Investor's Business Daily

Guardant Health Announces Clinical Result Update for Shield Blood-Based Colorectal Cancer Screening Test

September 04, 2025

Guardant Health to Host Investor Day on September 24, 2025

August 28, 2025

Guardant Health to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

August 26, 2025

Companies that burn cash at a rapid pace can run into serious trouble if they fail to secure funding. Without a clear path to profitability, these businesses risk dilution, mounting debt, or even...

3 Cash-Burning Stocks Walking a Fine Line

August 20, 2025

Topics Bankruptcy

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 15, 2025